Latest News in the pharma Industry

Top Stories

Medunik Canada & Orphan Europe Ink Deal

Medunik Canada & Orphan Europe Ink Deal

6 Jul 2012

Under the distribution agreement, Medunik Canada receives the exclusive Canadian rights to market and distribute four important therapies.

Read more 
Indian Generics Policy Is Bad News for Big Pharma

Indian Generics Policy Is Bad News for Big Pharma

6 Jul 2012

Pharmaceutical giants will suffer as a result of India's decision to hand out free generic medicines to its entire population.

Read more 
Amgen Completes Acquisition of KAI Pharmaceuticals

Amgen Completes Acquisition of KAI Pharmaceuticals

6 Jul 2012

Amgen has announced the completion of the acquisition of KAI Pharmaceuticals.

Read more 
Pharma Marketers Embracing Social Media

Pharma Marketers Embracing Social Media

5 Jul 2012

Websites such as Facebook and Twitter are increasingly being used by direct-to-consumer pharmaceutical marketing companies in markets where this type of advertising is allowed.

Read more 
AstraZeneca Teams up with Cellworks to Find New TB Treatment

AstraZeneca Teams up with Cellworks to Find New TB Treatment

4 Jul 2012

AstraZeneca and Cellworks have announced a Wellcome Trust-supported collaboration to speed up the design of new combination therapies for multi drug resistant TB.

Read more 
HGS Rejects GSK Extension of Unsolicited Tender Offer

HGS Rejects GSK Extension of Unsolicited Tender Offer

3 Jul 2012

Human Genome Sciences has rejected GlaxoSmithKline's latest extension to its tender offer.

Read more 
Bristol-Myers to Buy Diabetes Drug Maker Amylin for $5.3Bn

Bristol-Myers to Buy Diabetes Drug Maker Amylin for $5.3Bn

3 Jul 2012

Bristol-Myers Squibb and Amylin Pharmaceuticals have announced that the global biopharmaceutical giant is set to acquire the diabetes drug maker for approximately $5.3 billion.

Read more 
Argentina Proving Popular with CROs

Argentina Proving Popular with CROs

2 Jul 2012

A report by GBI Research has highlighted Argentina's increasing popularity as a cost-effective yet high-quality place to conduct clinical trials.

Read more 
Scientists Find Easier Way to Make New Drug Compounds

Scientists Find Easier Way to Make New Drug Compounds

2 Jul 2012

Bristol Myers Squibb will employ a novel technique to develop and manufacture drugs.

Read more 
Selvita & Orion Pharma Achieve a Research Milestone in Alzheimer’s Disease Program

Selvita & Orion Pharma Achieve a Research Milestone in Alzheimer’s Disease Program

2 Jul 2012

Selvita is responsible for the discovery and Orion is responsible for the development and global commercialization.

Read more 
Merck And AstraZeneca Amend Partnership, Agree Terms for Two More Years

Merck And AstraZeneca Amend Partnership, Agree Terms for Two More Years

29 Jun 2012

Merck and AstraZeneca have amended their US partnership, giving the latter a 2014 buyout option.

Read more 
5 Minutes with Hao Gao, Scientist, R&D, Dow Wolff Cellulosics

5 Minutes with Hao Gao, Scientist, R&D, Dow Wolff Cellulosics

29 Jun 2012

Hao Gao, scientist, R&D, Dow Wolff Cellulosics, believes that customers seek new technologies and designer solutions for a competitive edge and his company is committed to delivering these kinds of tailored solutions.

Read more